Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic

Finding a vaccine that can last a long time and effective against viruses with high mutation rates such as SARS-CoV-2 is still a challenge today. The various vaccines that have been available have decreased in effectiveness and require booster administration. As the professional antigen presenting c...

Full description

Bibliographic Details
Main Authors: Jonny Jonny, Terawan Agus Putranto, Raoulian Irfon, Enda Cindylosa Sitepu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
dendritic cells
immunotherapy
T cells
SARS-CoV-2
vaccine candidate
vaccine approach
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.989685/full

Similar Items

Similar Items